Enveda is a biotechnology company aiming to understand and utilize the chemistry that forms the foundation of life. Using their AI-powered tools to identify and characterize the diverse molecules that are produced by living organisms – the vast majority of which remain unknown to science – Enveda is creating a new database of chemical biodiversity to drive their drug discovery efforts. Enveda is re-energizing the field of natural product drug discovery, which had previously been deemed too slow, expensive, and failure-prone by big pharma. Enveda’s advanced technologies directly address the shortcomings of previous approaches, and they are progressing molecules through preclinical development at an exceptional pace. Over the last few months, we announced our clinical entry (in less than 4 years after our seed round), our new brand + look, and closed our Series C to deliver multiple PoCs, marking major validation of the company’s technology and foundational hypotheses.